These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3010398)

  • 21. Neuropathy and fatal hepatitis in a patient receiving amiodarone.
    Lim PK; Trewby PN; Storey GC; Hole DW
    Br Med J (Clin Res Ed); 1984 Jun; 288(6431):1638-9. PubMed ID: 6326931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Modifications and surveillance of thyroid tests during treatment with amiodarone].
    Lambert M; Burger A; Coche E; Ferrero C
    Ther Umsch; 1982 Feb; 39(2):114-6. PubMed ID: 7071783
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuropathy induced by amiodarone].
    Larre P; Coquet M; Maupetit J
    Nouv Presse Med; 1981 Sep; 10(33):2750. PubMed ID: 6270631
    [No Abstract]   [Full Text] [Related]  

  • 24. [Skin pigmentation after amiodarone administration. Histogenetic problems].
    Lambert D; Noble JP; Justrabo E; Hewitt J
    Ann Dermatol Syphiligr (Paris); 1975; 102(3):277-86. PubMed ID: 129026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone.
    Ahmad S
    Arch Intern Med; 1979 Nov; 139(11):1319. PubMed ID: 228621
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pigmentation caused by Cordarone].
    Varotti C; Tosti A; Colombati S; Tosti G; Veronesi S
    G Ital Dermatol Venereol; 1985; 120(3):183-6. PubMed ID: 4030015
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cutaneous pigmentation caused by amiodarone. Optical and ultrastructural study].
    Quintanilla E; Tuñón T; Fernández-Berridi D; Pardo-Mindán FJ
    Med Cutan Ibero Lat Am; 1982; 10(3):177-82. PubMed ID: 6759811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone.
    Tisdale JE; Follin SL; Ordelova A; Webb CR
    J Clin Pharmacol; 1995 Apr; 35(4):351-6. PubMed ID: 7650222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amiodarone-induced neuropathy of late appearance].
    Duboureau J; Jacquemier JM; Mazieres B; Arlet J
    Presse Med; 1983 Nov; 12(43):2766. PubMed ID: 6318212
    [No Abstract]   [Full Text] [Related]  

  • 30. [2 cases of peripheral neuropathy caused by amiodarone].
    Fischer C; Bady B; Trillet M; Schott B
    Nouv Presse Med; 1977 Nov; 6(39):3645-6. PubMed ID: 203895
    [No Abstract]   [Full Text] [Related]  

  • 31. Amiodarone: the experience of the past decade.
    McKenna WJ; Rowland E; Krikler DM
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1654-6. PubMed ID: 6416537
    [No Abstract]   [Full Text] [Related]  

  • 32. Myeloneuropathy, neurologic toxicity, and amiodarone.
    Neurology; 1985 Feb; 35(2):282-3. PubMed ID: 2982114
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical use of amiodarone.
    Dunn M
    Heart Lung; 1985 Jul; 14(4):407-11. PubMed ID: 3891691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone and the thyroid.
    Alves LE; Rose EP; Cahill TB
    Ann Intern Med; 1985 Mar; 102(3):412. PubMed ID: 3970485
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thyroid function and amiodarone: difficulties in the diagnosis and treatment (author's transl)].
    Wemeau JL; Decoulx M; Grimbert I; Ducloux G; Linquette M
    Therapie; 1982; 37(1):95-102. PubMed ID: 7089921
    [No Abstract]   [Full Text] [Related]  

  • 36. [Peripheral neuropathy induced by amiodarone].
    Domínguez R; Molina HA; Lia Taratuto A; Leiguarda R
    Medicina (B Aires); 1984; 44(4):347-55. PubMed ID: 6100498
    [No Abstract]   [Full Text] [Related]  

  • 37. [Amiodarone and thyroid function].
    Jonckheer MH; Broeckaert I; Blockx P; Bernard R
    Arch Mal Coeur Vaiss; 1976 Dec; 69(12):1315-9. PubMed ID: 827269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of thyroid dysfunction in patients during chronic treatment with amiodarone].
    Valenzuela MA; Bianchi C; Pineda G; Meruane J
    Rev Med Chil; 1985 Nov; 113(11):1072-5. PubMed ID: 3837294
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous pigmentation secondary to amiodarone therapy.
    Trimble JW; Mendelson DS; Fetter BF; Ingram P; Gallagher JJ; Shelburne JD
    Arch Dermatol; 1983 Nov; 119(11):914-8. PubMed ID: 6639112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side effects and possible contraindications of amiodarone use.
    Harris L; McKenna WJ; Rowland E; Krikler DM
    Am Heart J; 1983 Oct; 106(4 Pt 2):916-23. PubMed ID: 6613838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.